PF-06647020, a PTK7-targeted ADC made of a humanized antibody against PTK7 conjugated with the auristatin microtubule inhibitor Aur0101, also induced tumor regression in a subset of patient-derived xenograft models, without significant signs of toxicity [277,278]. The gene discussed is PTK7; the disease is neoplasm.